Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models

Por um escritor misterioso

Descrição

Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
β-catenin obstructs γδ T cell immunosurveillance in colon cancer
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
β-catenin obstructs γδ T cell immunosurveillance in colon cancer
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Cells, Free Full-Text
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Epsin is required for Dishevelled stability and Wnt signalling
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Wnt signaling in cancer
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Wnt/β-catenin signaling in colorectal cancer: Is therapeutic
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
New ZW4864 Derivatives as Small-Molecule Inhibitors for the β
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Differential regulation of β-catenin-mediated transcription via N- and
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
TBX3 acts as tissue-specific component of the Wnt/β-catenin
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Pygo and BCL9: the Wnt enhanceosome
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Apc Restoration Promotes Cellular Differentiation and
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
TBX3 acts as tissue-specific component of the Wnt/β-catenin
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Discovery of an Orally Bioavailable Small-Molecule Inhibitor for
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in  FAP mouse models
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
de por adulto (o preço varia de acordo com o tamanho do grupo)